NCT04282850View on ClinicalTrials.gov

Ablation Versus Medical Management of Atrial Fibrillation in HFpEF

NAUnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 10, 2023

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Atrial FibrillationHeart Failure With Normal Ejection Fraction
Interventions
PROCEDURE

Pulmonary Vein Isolation

The intervention will involve standard of care electrophysiology ablation for rhythm management of atrial fibrillation with a procedure called a pulmonary vein isolation.

Trial Locations (1)

22031

Inova Heart and Vascular Institute, Fairfax

Sponsors

Collaborators (1)

Medtronic
All Listed Sponsors
collaborator

Biosense Webster, Inc.

INDUSTRY

collaborator

Medtronic

INDUSTRY

lead

Johns Hopkins University

OTHER

NCT04282850 - Ablation Versus Medical Management of Atrial Fibrillation in HFpEF | Biotech Hunter | Biotech Hunter